Skip to main content

Advertisement

SpringerLink
Log in

Vascular Access Infections: Epidemiology, Diagnosis, and Management

  • Published:
Current Infectious Disease Reports Aims and scope Submit manuscript

Abstract

Infection is the most challenging and life-threatening complication of vascular access and causes significant morbidity, loss of access, and mortality. The aims of this review are to determine the magnitude of the infection problem, identify possible factors, and provide an update on the management of vascular access infections. Infections account for approximately 15% to 36% of all deaths in dialysis patients (the second leading cause after cardiovascular events) and for about 20% of admissions. Several studies demonstrate a hierarchy of infection risk from temporary catheter, tunnelled cuffed catheter, arteriovenous grafts, to arteriovenous fistula in decreasing order. Suspicion of infection must be followed by appropriate blood cultures, including possible simultaneous sampling from a peripheral vein and the access. The best way to treat vascular access infection is prevention, bearing in mind the idea “fistula first” and “lines last”, with the appropriate use of arteriovenous grafts and newer devices sandwiched in between.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: •Of importance, •• Of major importance

  1. Lok CE. Firstula first initiative: advantages and pitfalls. Clin J Am Soc Nephrol. 2007;2:1043–53.

    Article  PubMed  Google Scholar 

  2. Lemaire X, Morena M, Leray-Moragués H, et al. Analysis of risk factors for catheter-related bacteremia in 2000 permanent dual catheters for haemodialysis. Blood Purif. 2009;28:21–8.

    Article  PubMed  Google Scholar 

  3. • Li Y, Friedman JY, O'Neal BF, et al.: Outcomes of Staphylococcus aureus infection in haemodialysis-dependent patients. Clin J Am Soc Nephrol 2009, 4: 428–34. This article highlights the clinical and economic burdens of vascular access infection.

  4. Akoh JA, Riaz M. Management of patients with challenging vascular access needs. Int Surg. 2009;94:95–8.

    PubMed  Google Scholar 

  5. Schutte WP, Helmer SD, Salazar L, Smith JL. Surgical treatment of infected prosthetic dialysis arteriovenous grafts: total versus partial graft excision. Am J Surg. 2007;193:385–8.

    Article  PubMed  Google Scholar 

  6. Englesbe MJ, Al-Holou WN, Moyer AT, et al. Single centre review of femoral arteriovenous grafts for haemodialysis. World J Surg. 2006;30:171–5.

    Article  PubMed  Google Scholar 

  7. Ryan SV, Calligaro KD, Scharff J, Dougherty MJ. Management of infected prosthetic dialysis arteriovenous grafts. J Vasc Surg. 2004;39:73–8.

    Article  PubMed  Google Scholar 

  8. Foley RN, Guo H, Snyder JJ, et al. Septicaemia in the United States dialysis population. J Am Soc Nephrol. 2004;15:1038–45.

    Article  PubMed  Google Scholar 

  9. Barraclough KA, Hawley CM, Playford EG, Johnson DW. Prevention of access-related infection in dialysis. Expert Rev Anti Infect Ther. 2009;7:1185–200.

    Article  PubMed  Google Scholar 

  10. • Millar MR, Johnson G, Wilks M, et al.: Molecular diagnosis of vascular access device-associated infection in children being treated for cancer or leukaemia. Clinic Microbiol Infect 2008, 14: 213–20. This article describes a new test able to predict likelihood of VAD survival. The study was performed by laboratory staff working at distant site who were unaware of the clinical details of individual patients. Test results are available within a few hours, providing the potential for early specific intervention for VAD infection.

  11. NKF-KDOQI Clinical guidelines for vascular access. Am J Kidney Dis 2006, 48: S177-S276.

  12. Lafrance JP, Rahme E, Lelorier J, Iqbal S. Vascular access-related infections: definitions, incidence rates, and risk factors. Am J Kidney Dis. 2008;52:982–93.

    Article  PubMed  Google Scholar 

  13. Ponce P, Cruz J, Ferreira A, et al. A prospective study on incidence of bacterial infections in portuguese dialysis units. Nephron. 2007;107:c133–8.

    PubMed  Google Scholar 

  14. Saeed Abdulrahman I, Al-Mueilo SH, Bokhary HA, et al.: A prospective study of haemodialysis access-related bacterial infections. J Infect Chemotherapy 2002, 8: 242–6.

    Google Scholar 

  15. Mokrzycki MH, Zhang M, Cohen H, et al. Tunnelled haemodialysis catheter bacteraemia: risk factors for bacteraemia recurrence, infectious complications and mortality. Nephrol Dial Transplant. 2006;21:1024–31.

    Article  PubMed  Google Scholar 

  16. Tokars JI, Miller ER, Stein G. New national surveillance system for haemodialysis-associated infections: initial results. Am J Infect Control. 2002;30:288–95.

    Article  PubMed  Google Scholar 

  17. • Rodríguez-Aranda A, Alcazar JM, Sanz F, et al.: Endoluminal colonization as a risk factor for coagulase-negative staphylococcal catheter-related bloodstream infections in haemodialysis patients. Nephrol Dial Transplant. 2010 Aug 11. [Epub ahead of print]. This article looks at a readily available method to predict risk of catheter-related bloodstream infection.

  18. Alexandraki I, Sullivan R, Zaiden R, et al. Blood culture isolates in haemodialysis vascular catheter-related bacteremia. Am J Medical Sciences. 2008;336:297–302.

    Article  Google Scholar 

  19. Sychev D, Maya ID, Allon M. Clinical outcomes of dialysis catheter-related candidemia in haemodialysis patients. Clin J Am Soc Nephrol. 2009;4:1102–5.

    Article  PubMed  Google Scholar 

  20. Taylor G, Gravel D, Johnston L, et al. Canadian Hospital Epidemiology Committee. Canadian Nosocomial Infection Surveillance Program. Prospective surveillance for primary bloodstream infections occurring in Canadian haemodialysis units. Infect Control Hospital Epidemiol. 2002;23:716–20.

    Article  Google Scholar 

  21. Stevenson KB, Hannah EL, Lowder CA, et al. Epidemiology of haemodialysis vascular access infections from longitudinal infection surveillance data: predicting the impact of NKF-DOQI clinical practice guidelines for vascular access. Am J Kidney Dis. 2002;39:549–55.

    Article  PubMed  Google Scholar 

  22. Wasse H. Catheter-related mortality among ESRD patients. Semin Dial. 2008;21:547–9.

    Article  PubMed  Google Scholar 

  23. Colville LA, Lee AH. Retrospective analysis of catheter-related infections in a haemodialysis unit. Infect Control Hospl Epidemiol. 2006;27:969–73.

    Article  Google Scholar 

  24. Collins AJ, Foley RN, Gilbertson DT, Chen SC. The state of chronic kidney disease, ESRD, and morbidity and mortality in the first year of dialysis. Clin J Am Soc Nephrol. 2009;4:S5–11.

    Article  PubMed  Google Scholar 

  25. Rehman R, Schmidt RJ, Moss AH. Ethical and legal obligation to avoid long-term tunneled catheter access. Clin J Am Soc Nephrol. 2009;4:456–60.

    Article  PubMed  Google Scholar 

  26. Yildizeli B, Lacin T, Batirel HF, Yuksel M. Complications and management of long-term central venous access catheters and ports. J Vasc Access. 2004;5:174–8.

    PubMed  CAS  Google Scholar 

  27. Dendle C, Martin RD, Cameron DR, et al. Staphylococcus aureus bacteraemia as a quality indicator for hospital infection control. Med J Aust. 2009;191:389–92.

    PubMed  Google Scholar 

  28. Churchill DN, Taylor DW, Cook RJ, et al. Canadian Haemodialysis morbidity study. Am J Kidney Dis. 1992;19:214–34.

    PubMed  CAS  Google Scholar 

  29. Schild AF, Simon S, Prieto J, Raines J. Single-centre review of infections associated with 1574 consecutive vascular access procedures. Vasc Endovasc Surg. 2003;37:27–31.

    Article  Google Scholar 

  30. Akoh JA, Patel N. Infection of haemodialysis arteriovenous grafts. J Vasc Access. 2010;11:155–8.

    PubMed  Google Scholar 

  31. Salimi J. Patency rate and complications of vascular access grafts for haemodialysis in lower extremities. Saudi J Kidney Dis Transplant. 2008;19:929–32.

    Google Scholar 

  32. Antoniou GA, Lazarides MK, Georgiadis GS, et al. Lower-extremity arteriovenous access for haemodialysis: a systematic review. Eur J Vasc Endovasc Surg. 2009;38:365–72.

    Article  PubMed  CAS  Google Scholar 

  33. Geenen IL, Nyilas L, Stephen MS, et al.: Prosthetic lower extremity haemodialysis access grafts have satisfactory patency despite a high incidence of infection. J Vasc Surg 2010 Aug 21. [Epub ahead of print]

  34. Abreo KD, Ram SJ. Thigh grafts: a preferable alternative to catheters when upper extremity access sites are exhausted. Semin Dial. 2009;22:469–71.

    Article  PubMed  Google Scholar 

  35. Tokars JI, Light P, Anderson J, et al. A prospective study of vascular access infections at seven outpatient haemodialysis centres. Am J Kidney Dis. 2001;37:1232–40.

    Article  PubMed  CAS  Google Scholar 

  36. • Lafrance JP, Iqbal S, Lelorier J, et al.: Vascular access-related bloodstream infections in First Nations, community and teaching Canadian dialysis units, and other centre-level predictors. Nephron Clin Pract. 2010, 114: c204-12. This retrospective cohort study includes various types of dialysis centers, which makes the findings generalizable to the entire population. Center level risks of bloodstream infection are not significantly different.

  37. • Reddy S, Sullivan R, Zaiden R, et al.: Hepatitis C infection and the risk of bacteremia in haemodialysis patients with tunneled vascular access catheters. South Med J. 2009, 102: 374–7. This article shows that HCV patients with detectable virus are at increased risk of CVC-related bacteremia.

    Google Scholar 

  38. Salman L, Asif A. Antibiotic prophylaxis: is it needed for dialysis access procedures? Semin Dial. 2009;22:297–9.

    Article  PubMed  Google Scholar 

  39. van Loon MM, Goovaerts T, Kessels AG, et al. Buttonhole needling of haemodialysis arteriovenous fistulae results in less complications and interventions compared to the rope-ladder technique. Nephrol Dial Transplant. 2010;25:225–30.

    Article  PubMed  Google Scholar 

  40. Troidle L, Eisen T, Pacelli L, Finkelstein F. Complications associated with the development of bacteraemia with Staphylococcus aureus. Haemodialysis Int. 2007;11:72–5.

    Google Scholar 

  41. Desai M, Rapoor R, Gudithi SL, et al. Endophthalmitis: a rare complication of arteriovenous fistula infection. Haemodialysis Int. 2008;12:227–9.

    Article  Google Scholar 

  42. Fernandez-Cean J, Alvarez A, Burguez S, et al. Infective endocarditis in chronic haemodialysis: two treatment strategies. Nephrol Dial Transplant. 2002;17:2226–30.

    Article  PubMed  CAS  Google Scholar 

  43. •• Mermel LA, Allon M, Bouza E, et al.: Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. Clin Infect Dis 2009, 49: 1–45. These are comprehensive clinical practice guidelines for management of CVC/VAD-related infection. Analysis of data published from 2001 to 2008 was used to update the 2001 guidelines. The guidelines were written by an expert panel with widespread representation from America and Europe.

  44. Raad I, Hanna H, Maki D. Intravascular catheter-related infections: advances in diagnosis, prevention, and management. Lancet Infect Dis. 2007;7:645–57.

    Article  PubMed  Google Scholar 

  45. Higgins M, Evans DS. Nurses' knowledge and practice of vascular access infection control in haemodialysis patients in the Republic of Ireland. J Renal Care. 2008;34:48–53.

    Article  Google Scholar 

  46. Easterlow D, Hoddinott P, Harrison S. Implementing and standardising the use of peripheral vascular access devices. J Clinic Nursing. 2010;19:721–7.

    Article  Google Scholar 

  47. Patel PR, Kallen AJ, Arduino MJ. Epidemiology, surveillance, and prevention of bloodstream infections in haemodialysis patients. Am J Kidney Dis. 2010;56:566–77.

    Article  PubMed  Google Scholar 

  48. • Rabindranath KS, Bansal T, Adams J, et al.: Systematic review of antimicrobials for the prevention of haemodialysis catheter-related infections. Nephrol Dial Transplant. 2009; 24: 3763–74. This article is a systematic review of 29 trials involving 3005 catheters in 2886 patients showing antimicrobial locks and exit site antimicrobials reduce CVC infections.

  49. Tercier S, Gapany C, Diezi M, et al. Incidents and complications of totally implanted vascular access devices in children: a prospective study. Patient Saf Surg. 2008;2:30.

    Article  PubMed  Google Scholar 

  50. • Katzman HE, McLafferty RB, Ross JR, et al.: Initial experience and outcome of a new haemodialysis access device for catheter-dependent patients. J Vasc Surg 2009; 50: 600–7, 607.e1. This article describes a new device for ensuring access in patients with central venous obstruction.

Download references

Disclosure

The author reports no potential conflict of interest relevant to this article.

Disclaimers

None

Author information

Authors and Affiliations

  1. Gastroenterology, Surgery & Renal Services Directorate, Plymouth Hospitals NHS Trust, Derriford Hospital, Plymouth, PL6 8DH, UK

    Jacob A. Akoh

Authors
  1. Jacob A. Akoh
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jacob A. Akoh.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Akoh, J.A. Vascular Access Infections: Epidemiology, Diagnosis, and Management. Curr Infect Dis Rep 13, 324–332 (2011). https://doi.org/10.1007/s11908-011-0192-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11908-011-0192-x

Keywords

Search

Navigation